- Issuer ticker
-
CPIX
- Reported as of
-
18 Mar 2026
- Net transaction value
-
$0
- SEC form
-
4
- Accepted by SEC
-
20 Mar 2026, 17:20:05 UTC
Filing notes and source
Key filing fact
James L. Herman filed Form 4 for CUMBERLAND PHARMACEUTICALS INC (CPIX) on 20 Mar 2026.
Key facts
- This page summarizes James L. Herman's Form 4 filing for CUMBERLAND PHARMACEUTICALS INC (CPIX).
- 1 reported transaction and 1 derivative row are listed below.
- Accepted by SEC: 20 Mar 2026, 17:20.
Change
- Previous filing in this sequence was filed on 18 Mar 2025.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
Ownership activity is grounded in SEC Form 4 disclosures.
View source filing
Reporting Owners (1)
CIK 0001572342
Primary reporting owner
Herman James L
- Relationship
-
VP and Chief Compliance Office
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
CPIX
transaction
Derivative
Options (right to buy)
Award
- Transaction value
- Shares
- +2,500
- Change %
- +14%
- Price
-
$2.80*
- Shares after
- 21,000
- Date
- 18 Mar 2026
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 2,500
- Exercise price
- $2.80
* marks a reported price that did not pass the local price check.